Pain in Psychiatry : Impact on Length of Hospital Stays

NCT ID: NCT02822430

Last Updated: 2016-07-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

137 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-04-30

Study Completion Date

2015-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For several decades, authors are interested in the existence and meaning of painful symptoms in a population of psychiatric inpatients. But, to date, studies specifically focused on the impact of pain in patient populations in psychiatric hospitals are few. More recently, a review of the literature highlights the difficulties of evaluation of pain in populations of psychiatric patients but also the complex interrelationships between painful symptoms and psychiatric diseases. The first national survey conducted among 172 health which evaluate pain and its management in the field of psychiatry concluded on the need to develop research in this area.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pain in all the populations remains a major public health issue. Patients with mental illness consult less their general practitioners while they have an increased risk of physical disease. In addition, they have a net reduction in life expectancy due to their mental illness, living conditions and drug treatments.

In this particular population, doctors faces especially difficulties assessment and treatment of pain. Indeed, there is for example in some of these patients difficulties to express that pain.

These painful events make more complex the care of hospitalized patients (eg interrelationship between pain complaints and psychiatric symptoms) and seem to lengthen their hospital stay. This is not without consequences as long as hospitalizations represent an obstacle to the patients psychosocial rehabilitation (installation of daytime activities, project work rehabilitation, development of social network ...) and impair their quality of life.

And for the patients with psychiatric disorders some points can be noticed :

* An increased risk of physical disease
* Warning signs like pain poorly known and poorly evaluated ... and poorly supported
* The presence of the pain seems to lengthen the hospital stay
* An extension of the hospital stay, which represent an obstacle to the psychosocial rehabilitation This research project is to test if the presence of a painful complaint among psychiatric inpatients is associated lengthening of the hospitalization duration.

The secondary objectives of this study are:

* To measure the prevalence of painful complaint in this specific population,
* To examine the evolution of pain during hospitalization.
* Identify factors influencing the relationship between pain and length of stay
* To identify if the intensity of the psychiatric illness is associated with pain intensity measured

Confirmation of these objectives would lead to a better understanding of the factors influencing psychiatric hospital stays and thus more efficient management of health resources.

In addition, the present study will well identify and implement standardized assessments of pain for these patients.

For these patients the interest is important because they can be in great difficulty to express a painful complaint. These people have often difficulties to communicate, and live in a sometimes precarious environment and severity of disorders reduce their access to care.

This approach is part of a comprehensive approach taking account of the psychiatric and somatic disorders in a very vulnerable population.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients

Patients with psychiatric disorders will be assessed using five evaluation of pain scales :

* Visual analogic scale pain
* Pain behaviour scale
* Short-FormHealth Survey (SF-36)
* Global Clinical Impression (GCI) for severity and improvement
* Mini International Neuropsychiatric Interview (MINI)

Pain scales

Intervention Type OTHER

* Visual analogic scale of pain
* Pain behaviour scale
* Short-FormHealth Survey (SF-36)
* Clinical Global impression
* Mini International Neuropsychiatric Interview (MINI)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pain scales

* Visual analogic scale of pain
* Pain behaviour scale
* Short-FormHealth Survey (SF-36)
* Clinical Global impression
* Mini International Neuropsychiatric Interview (MINI)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient eighteen years old
* Patient hospitalized in psychiatric service at Toulouse University Hospital
* Informed consent signed

Exclusion Criteria

* Patient treated with maintenance sismotherapy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Toulouse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laurent SCHMITT, PHD, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Toulouse

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Functionnal unit of psychiatry

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC31-13-7017

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pain and Schizophrenia
NCT01244542 TERMINATED NA